None
Conditions
Interventions
Tablets containing 600 mg of hydrous ethanol extract of plant seeds
Sponsors
Akasaka Family Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Healthy and free from chronic physical disease. The applicant must be able to give consent to participate in the study in writing after having been fully informed of the purpose and content of the study and having the ability and understanding of the study. The applicant must be able to come to the hospital on the designated date and undergo the examination. Those who are deemed suitable by the investigator to participate in the study.
Exclusion criteria
Exclusion criteria: Those who are currently undergoing drug treatment for some disease. Patients with a history or current history of serious disorders of the liver, kidney, heart, lungs, blood, etc. Patients with a history of co-morbidities or a history of gastrointestinal disorders. Patients with alcohol dependence or other psychiatric disorders Patients who have taken any medication for the purpose of treatment of disease in the past 1 month (except for abrupt administration of medication for headache, menstrual cramps, common cold, etc.). The specific hay fever symptoms include: Birch: alder, birch, cedar, Japanese cypress; Asteraceae: ragweed, mugwort; Poaceae: ragweed, mugwort; Poaceae: chamogaya, Japanese mugwort; and Poaceae: Japanese knotweed, Japanese millet. Persons who may develop allergic symptoms to any of the ingredients in the tested foods, or who may develop serious allergic symptoms to other foods or medicines. Persons with severe anemia Persons who have a smoking habit. Women: Pregnant, lactating, or planning to become pregnant during the study period. Those who may change their lifestyle during the study period (e.g., work at night, travel for long periods, etc.). Those who are currently, or within the past 3 months have been, or will be taking functional foods, health foods, or supplements containing the ingredients of the food under study. Those who have undergone medical treatment involving hospitalization within the past 6 months. Those who have participated in other clinical studies within one month of obtaining consent to participate in this study, or those who plan to participate in other clinical studies after obtaining consent to participate in this study. Other subjects who are judged by the investigator to be inappropriate for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hematological tests Blood Biochemistry Urinalysis Height, weight, BMI Measurement of systolic and diastolic blood pressure and pulse rate Interview by physician | — |
Countries
Japan
Contacts
Public ContactSadao Mori
MORINAGA & CO., LTD. R & D Center
Outcome results
None listed